ImmunoGen, Inc.: capex
| Value | {"amount": 893000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-03-31 |
| Status | current |
| Entity | ImmunoGen, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:28:08.271109+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d2f1f127-d9a0-4cd9-b2a7-baf195bc05d1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-21-006659 · Open the official SEC filing →Retrieved: 2026-08-19T08:28:08.271109+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000855654/capex/2021-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d2f1f127-d9a0-4cd9-b2a7-baf195bc05d1
History
- no predecessors — first report